Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Cepheid Falls After Cutting Sales Forecast: San Francisco Mover

Don't Miss Out —
Follow us on:

Sept. 27 (Bloomberg) -- Cepheid Inc., a maker of medical tests, plunged the most in two months after cutting its third-quarter sales forecast.

Cepheid declined 10 percent to $35.18 at the close in New York, its biggest one-day drop since July 20.

Sales for the quarter will be $79 million to $81 million, the Sunnyvale, California-based company said in a statement yesterday. Interruptions in the supply of Xpert cartridge parts will postpone more than $5 million in orders past the end of the quarter, Cepheid said. The company left its full-year sales forecast unchanged at $333 million to $347 million.

“We have notified customers that we are working diligently to fulfill orders as quickly as possible, but this will take several more weeks, pushing fulfillment of some orders from the third quarter into the fourth quarter,” Chief Executive Officer John Bishop said in a statement.

To contact the reporter on this story: Drew Armstrong in New York at +1-212-617-8933 or

To contact the editor responsible for this story: Reg Gale at